Feature | HER2 gene copy number in serum | X2 p | |
---|---|---|---|
Below the median N = 38 (49%) | Above the median N = 40 (51%) | ||
Age (n = 78) | |||
< 62 | 17 (50) | 17 (50) | 0.04 0.8 |
≥ 62 | 21 (48) | 23 (52) | |
Gender (n = 78) | |||
Male | 29 (45) | 35 (55) | 1.655 2.2 |
Female | 9 (64) | 5 (36) | |
Histopathological diagnosis (n = 68) | |||
Tubular | 15 (54) | 13 (46) | 0.983 0.9 |
Mucinous | 5 (64) | 3 (36) | |
Poorly cohesive | 10 (53) | 9 (47) | |
Poorly differentiated | 4 (67) | 2 (33) | |
No data | 3 (43) | 4 (57) | |
Laurent type (n = 67) | |||
Intestinal | 10 (56) | 8 (44) | 3.110 0.37 |
Diffuse | 9 (69) | 4 (31) | |
Mixed | 2 (29) | 5 (71) | |
No data | 15 (52) | 14 (48) | |
Grading (n = 67) | |||
G1 | 1 (33) | 2 (67) | 2.271 0.69 |
G2 | 16 (57) | 12 (43) | |
G3 | 15 (58) | 11 (42) | |
G4 | 0 (0) | 1 (100) | |
ND | 4 (44) | 5 (56) | |
cTNM (n = 67) | |||
1A-IIIA | 15 (65) | 8 (35) | 1.859 0.17 |
IIIB-IV | 21 (48) | 23 (52) | |
IHC (n = 19) | |||
Negative | 4 (44) | 3 (56) | 0.686 0.7 |
Low expression of HER2 (+ or ++) | 4 (80) | 1 (20) | |
High expression of HER2 (+++) | 2 (67) | 1 (33) | |
Treatment (n = 78) | |||
PAL | 10 (40) | 15 (60) | 5.757 0.33 |
CHTH | 0 (0) | 3 (100) | |
CHRTH | 1 (25) | 3 (75) | |
CHTH + OP | 14 (56) | 11 (44) | |
CHRTH + OP | 5 (56) | 4 (44) | |
OP | 5 (42) | 7 (58) |